Radioiodine ablation in low-risk thyroid cancer.
作者信息
Loo Suat W
出版信息
N Engl J Med. 2012 Aug 16;367(7):672-3; author reply 674. doi: 10.1056/NEJMc1206712.
PMID:22894583
Abstract
摘要
相似文献
1
Radioiodine ablation in low-risk thyroid cancer.
N Engl J Med. 2012 Aug 16;367(7):672-3; author reply 674. doi: 10.1056/NEJMc1206712.
2
Radioiodine ablation in low-risk thyroid cancer.
N Engl J Med. 2012 Aug 16;367(7):672; author reply 673-5. doi: 10.1056/NEJMc1206712.
3
Radioiodine ablation in low-risk thyroid cancer.
N Engl J Med. 2012 Aug 16;367(7):673; author reply 674. doi: 10.1056/NEJMc1206712.
4
Radioiodine for thyroid cancer--is less more?
N Engl J Med. 2012 May 3;366(18):1732-3. doi: 10.1056/NEJMe1202172.
5
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.
N Engl J Med. 2012 May 3;366(18):1674-85. doi: 10.1056/NEJMoa1109589.
6
Thyroid cancer: successful remnant ablation-what is success?
Nat Rev Endocrinol. 2012 Sep;8(9):514-5. doi: 10.1038/nrendo.2012.113. Epub 2012 Jul 3.
7
Well-being after radiation therapy in thyroid cancer.
N Engl J Med. 2013 Feb 14;368(7):685-6. doi: 10.1056/NEJMc1212592.
8
9
High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawal.
Thyroid. 2014 Mar;24(3):480-7. doi: 10.1089/thy.2013.0157. Epub 2014 Jan 17.
10
Radioiodine therapy of metastatic lesions of differentiated thyroid cancer.
J Endocrinol Invest. 2012;35(6 Suppl):21-9.
Zotero 插件